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The recognition that T cell growth factor (TCGF)
can maintain T cells in long-term culture offers the
opportunity of expanding populations of
monoclonal antigen-specific T lymphocytes with
helper, suppressor or cytotoxic activity (Fathman &
Fitch, 1982). The application of this technology in
the generation of tumour reactive T cells for the
analysis of tumour antigen recognition and their
therapeutic potential in the management of
malignant disease has evoked much investigation.
Indeed, human T cell lines reactive against solid
tumours (Vanky et al., 1982; Kedar et al., 1983)
and tumour cell lines (Zarling & Bach, 1979;
Mitsuya et al., 1983) have been propagated in
culture with TCGF. For the most part these were
derived from the cocultivation of tumour and
lymphoid cells and resulted in the induction of T
cell lines with cytotoxic activity.
The aim of this study was to analyze the hetero-
geneity of specificity of the T cell response in the
peripheral blood of a patient who had a lobectomy
for a pulmonary adenocarcinoma. Oligoclonal
human T lymphocyte lines were induced with auto-
logous pulmonary adenocarcinoma cells. Briefly,
peripheral blood lymphocytes taken 3 weeks post
operatively (PBL; 2.5 x 105ml-1) were stimulated
for 6 days in the absence of TCGF with a detergent
extract (0.5% NP-40, BDH) of autologous tumour
(10/Mgml-1) which contains solubilized membrane
and cytoplasm. The antigen concentration required
to produce optimal stimulation had been
determined previously. Concentrations of the
extract expressed as /ugml-1 are based on the
protein content determined by OD280. Viable cells
from these cultures were isolated on a Ficoll-
Hypaque density gradient and the lymphoblasts
(20% of the viable cells) were resuspended in
RPMI-1640 medium (Gibco, Grand Island, NY)
supplemented with 10% pooled A' serum and 20%
TCGF and plated at 3 cellswell-I in microtest II
trays (Falcon) with 104 irradiated (30Gy) auto-
logous PBL and tumour extract (10ygml-1) as
previously described (Lamb et al., 1982a). TCGF
was prepared by culturing PBL (106ml) with 0.1%
purified phytohaemagglutinin (PHA-P; Difco) in
the presence of 2.5% pooled A' serum. After 48h
supernatants were collected and assayed for their
ability to support the growth of a TCGF dependent
line. Growing lines were expanded with the
addition of fresh TCGF every 3-4 days and with
pooled irradiated allogeneic PBL (5 x IO'ml 1) as
"filler" cells every 7 days. Since the plating
efficiency was 3.4% it is possible that clonal
populations of T cells had been isolated. Before use
in experiments the lines were rested for 7 days after
the addition of filler cells. To assay for antigen
specificity the oligoclonal T cells (2.5 x O4ml-1)
were cultured with extracts (10Mgml-') of auto-
logous tumour, autologous activated T cells, allo-
geneic anaplastic pulmonary large cell carcinoma or
allogeneic adenosquamous carcinoma of the lung in
the presence of irradiated autologous PBL
(1.25 x 105ml-1) in 200M1 in 96 well round bottom
microtitre plates without added TCGF. The PBL
used in the specificity assays were the same as those
used in the induction of the lines. The Background
response of PBL to each of the extracts tested was
<600 cpm. Following 60h incubation the cultures
were pulsed for 8-16h with 1.0 MCi of tritiated
thymidine [3H]-dT; (Radiochemicals Inc.,
Amersham) and harvested onto glass fibre filters.
Proliferation as correlated with [3H]-dT incor-
poration was measured by liquid scintillation
spectroscopy. The results are expressed as mean
cpm + s.e. of the mean of triplicate cultures.
It is interesting that analysis of the general
pattern of anti-tumour specificity revealed that all
the oligoclonal T cell lines responded to the auto-
logous tumour cell extract; however with more
detailed investigation, distinct patterns of reactivity
could be observed (Table I). Firstly, there were
those lines (13.4, 42.4 and 42.5) that proliferated in
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Table I Antigen specificity of tumour induced oligoclonal T cell lines
[311]-dT incorporationa in the presence of:
Pulmonary tumour extracts other extracts/factors
Allogeneic Allogeneic Autologous
Autologous adeno-squamous large cell Autologous adenocarcinoma
adenocarcinoma carcinoma carcinoma Tcell extract Medium TCGF +TCGF
CTL 9795162b 8041+256 7518+823 643+ 84 576+ 71 4333+894 5605+400
13.4 3890+225 3910+203 4722+694 4538+120 277+ 22 3083+ 22 4144+262
42.4 3529+897 3079+539 4659+234 6585+189 95+ 5 3292+122 2399+101
42.5 6291+819 5523+528 4367+453 5348+ 31 154+ 29 2882+596 2773+267
42.8 5289±925 5299+614 3778±758 5380+415 1883+229 2607+423 4360±498
13.3 3690+590 4325±655 433+ 71 4427±573 439+ 23 2421+225 2785±189
42.9 4852+429 3795+624 467+155 2640+ 89 296+ 90 4697+279 2876±137
13.25 6360±404 271+ 39 309+ 31 5639+467 182+ 11 3289+341 NT
13.26 6861+1169 327± 75 393+ 79 6571+438 383+ 32 4607±116 NT
13.5 3456±234 3075±168 3476±339 311± 14 365+ 33 2735±401 2991±457
42.10 5540±616 659±172 637±142 638±205 263± 26 5253±328 4535± 12
346+196 233+ 19 574+122 256+ 59 419+117
'T cell line (2.5 x lO4m m ) cultured with (10pgmlP ) of extracts in the presence of irradiated autologous PBL
(1.25 x 10 ml- 1). Proliferation as determined by [3H]-dT incorporation measured at 72h.
bCpm+s.e.
NT. not tested.
response to all the cell extracts used including
autologous T cells. There are several explanations
for this pattern of specificity. The lines may
recognize an activation antigen such as the trans-
ferrin receptor present on both T lymphocytes and
tumour cells. Alternatively, they are non-specific
and are merely activated by the culture conditions
or by "back stimulation" resulting in TCGF release
from the interaction of antigen and PBL (Lamb et
al., 1982a). A single line, 42.8, showed a similar
pattern of antigen reactivity. The high background
proliferation when cultured alone in medium may
reflect autoactivation resulting in the production of
TCGF by the line itself. The second main pattern
of reactivity is observed with 13.3 and 42.9 which
recognize the autologous tumour and autologous T
cells in addition to determinants of the allogeneic
adenosquamous cell extract but not allogeneic large
cell carcinoma. It is difficult from these results to
postulate the determinant of tumour recognition
and again activation antigens appear as possible
candidates. Lines 13.25 and 13.26 proliferate in
response to only the autologous tumour and T cell
extracts. These lines may be recognizing an acti-
vation or differentiation antigen only on autologous
cells. It is possible that self (HLA) determinants
may be inducing the response, analogous to an
autologous mixed lymphocyte reaction. The final
category of responsiveness is the most informative
in that it appears to be tumour antigen related. T
cell line 13.5 proliferates when stimulated with
membrane extracts of autologous and allogeneic
tumour cells independently of their histological
type. No proliferation was observed in response to
autologous T cells. Tentatively this result may be
interpreted as suggesting that a common or cross
reactive tumour antigen is recognized by this T cell
line. Interestingly, the polyclonal T cell line (CTL)
showed a similar pattern of specificity with minimal
recognition of autologous T cell antigens. It is
possible that the cross-reactive responses observed
are merely because T cell line (13.5) was not
monoclonal, since 3 blast cells were plated per well.
However, as suggested by the failure of the poly-
clonal line (CTL) to respond to all cell extracts it is
unlikely that heterogeneous blast cells expand
uniformly. In contrast to the recognition of cross-
reactive determinants, line 42.10 recognized a
determinant unique to the autologous tumour cells
in that a proliferative response was observed only
after stimulation with this and not the control
membrane extracts. Furthermore, this line failed to
proliferate in response to foetal lung extract
(513+132cpm). Therefore it is tempting to
interpret this response as that of tumour specific
reactivity.
Similar to our findings, Vose & Bonnard (1982a,
b) were able to demonstrate human T cells cultured
in TCGF which both showed cytotoxic and
proliferative activity against solid tumour cells. The
proliferative responses were directed against auto-
logous and allogeneic tumours of the same
anatomical site and cell type, but no reactivity to
unrelated tumour could be detected (Vose &
Bonnard, 1982b). However, the analysis reported
here demonstrates a more diverse repertoire ofHETEROGENEITY OF TUMOUR REACTIVE T CELLS 661
antigen specificities in that both cross reactive and
tumour specific T cell lines were identified. This
may be explained partly by the fact that in the
present study after only 6 days primary in vitro
culture in the absence of TCGF oligoclonal lines
were isolated. In addition the manner in which the
antigen is presented either on the tumour cell
surface or as a soluble extract may influence the
repertoire of T cells selected, as has been reported
for example, for influenza virus immune T cells
(Lamb et al., 1982b). The heterogeneity of the
antigen specificity observed in the oligoclonal lines
induced with autologous tumour extract raises the
possibility that multiple determinants might be
critical for T cell tumour antigen recognition. This
stresses the necessity for cloning anti-tumour
responsive cells early and analysing the specificity
and interaction of these cells in the overall immune
response.
As a cautionary note, we were unable to
maintain these lines in culture beyond 50 days
similar to other laboratories. This perhaps was
largely due to being unable to acquire an adequate
number of autologous PBL for maintaining the
lines and the failure to culture the tumour cells in
vitro. However, despite such problems this
approach may allow the identification of tumour
associated determinants that appear to be unique or
cross reactive. It is this latter category of
determinants that offer the widest range of
potential in tumour immunology.
We thank Drs P.C.L. Beverley and M. Feldmann for
helpful discussions.
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